Combination effect of pentoxifylline and etoposide on a human lung cancer cell line
Ishida, S.; Fujiuchi, S.; Akiba, Y.; Osanai, S.; Tsuji, T.; Nakano, H.; Matsumoto, H.; Ohosaki, Y.; Fujikane, T.; Onodera, S.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 18(7): 1217-1220
1991
ISSN/ISBN: 0385-0684
PMID: 2053781
Accession: 039604472
PDF emailed within 1 workday: $29.90
Related References
Kanzawa, F.; Nishio, K.; Fukuoka, K.; Fukuda, M.; Kunimoto, T.; Saijo, N. 1997: Evaluation of synergism by a novel 3-D model for the combination effect of cisplatin and etoposide on a human small cell lung cancer cell line, SBC-3 Proceedings of the American Association for Cancer Research Annual Meeting 38: 318Reck, M.; Horn, L.; Novello, S.; Barlesi, F.; Albert, I.án.; Juhász, E.éb.; Kowalski, D.; Robinet, G.; Cadranel, J.; Bidoli, P.; Chung, J.; Fritsch, A.; Drews, U.; Wagner, A.; Govindan, R. 2019: Phase Ii Study of Roniciclib in Combination with Cisplatin/Etoposide or Carboplatin/Etoposide as First-Line Therapy in Patients with Extensive-Disease Small Cell Lung Cancer Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 14(4): 701-711
Ohsaki, Y.; Ishida, S.; Fujikane, T.; Kikuchi, K. 1996: Pentoxifylline potentiates the antitumor effect of cisplatin and etoposide on human lung cancer cell lines Oncology 53(4): 327-333
Smith, I.E.; Evans, B.D.; Gore, M.E.; Vincent, M.D.; Repetto, L.; Yarnold, J.R.; Ford, H.T. 1987: Carboplatin (Paraplatin; JM8) and etoposide (VP-16) as first-line combination therapy for small-cell lung cancer Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 5(2): 185-189
Gatzemeier, U.; Hossfeld, D.K.; Neuhauss, R.; Reck, M.; Achterrath, W.; Lenaz, L. 1992: Combination chemotherapy with carboplatin, etoposide, and vincristine as first-line treatment in small-cell lung cancer Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 10(5): 818-823
Zarogoulidis, K.; Mylonaki, E.; Kakavelas, P.; Zarogoulidis, P.; Tsiouda, T.; Rapti, E.; Lithoxopoulou, H.; Zarogoulidou, V.; Kontakiotis, T. 2009: Topotecan-carboplatin-etoposide combination as 1st line treatment in patients with small cell lung cancer Lung Cancer 66(2): 226-230
Ellis, P.A.; Talbot, D.C.; Priest, K.; Jones, A.L.; Smith, I.E. 1995: Dose intensification of carboplatin and etoposide as first-line combination chemotherapy in small cell lung cancer European Journal of Cancer 31a (11): 1888-1889
Jiang, S.; Huang, L.; Zhen, H.; Jin, P.; Wang, J.; Hu, Z. 2021: Carboplatin versus cisplatin in combination with etoposide in the first-line treatment of small cell lung cancer: a pooled analysis Bmc Cancer 21(1): 1308
Choi, H.Jin.; Cho, B.Chul.; Shin, S.Joon.; Cheon, S.Ha.; Jung, J.Yul.; Chang, J.; Kim, S.Kyu.; Sohn, J.Hyuk.; Kim, J.Hang. 2008: Combination of topotecan and etoposide as a salvage treatment for patients with recurrent small cell lung cancer following irinotecan and platinum first-line chemotherapy Cancer ChemoTherapy and Pharmacology 61(2): 309-313
Sculier, J.P.; Lafitte, J.J.; Lecomte, J.; Berghmans, T.; Thiriaux, J.; Van Cutsem, O.; Efremidis, A.; Ninane, V.; Paesmans, M.; Mommen, P.; Klastersky, J. 2002: A phase Ii randomised trial comparing the cisplatin-etoposide combination chemotherapy with or without carboplatin as second-line therapy for small-cell lung cancer Annals of Oncology: Official Journal of the European Society for Medical Oncology 13(9): 1454-1459
Banerjee, S.; Tomiak, E.; Goel, R.; Stewart, D. 1999: Effects of taxotere and etoposide combination in two human lung cancer cell lines Proceedings of the American Association for Cancer Research Annual Meeting 40: 681
Doyle, J.J.; Dezii, C.M.; Sadana, A. 1996: A pharmacoeconomic evaluation of cisplatin in combination with either etoposide or etoposide phosphate in small cell lung cancer Seminars in Oncology 23(6 Suppl 13: 51-60
Miyamoto, H.; Ito, M.; Araya, Y.; Takaoka, K.; Isobe, H.; Dosaka, H.; Inoue, S.; Kawakami, Y.; Mizuno, S. 1984: Etoposide effect on cell cycle kinetics of a human lung cancer cell line Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(6): 1237-1243
Minato, K.; Kanzawa, F.; Nishio, K.; Nakagawa, K.; Fujiwara, Y.; Saijo, N. 1990: Characterization of an etoposide-resistant human small-cell lung cancer cell line Cancer ChemoTherapy and Pharmacology 26(5): 313-317
Takigawa, N.; Ohnoshi, T.; Ueoka, H.; Kiura, K.; Kimura, I. 1992: Establishment and characterization of an etoposide-resistant human small cell lung cancer cell line Acta Medica Okayama 46(3): 203-212
Charpidou, A.; Tsagouli, S.; Tsimpoukis, S.; Vassias, A.; Makrilia, N.; Stratakos, G.; Gkiozos, I.; Syrigos, K. 2010: Triplet combination of carboplatin, irinotecan, and etoposide in the first-line treatment of extensive small-cell lung cancer: a single-institution phase II study Anti-Cancer Drugs 21(6): 651-655
Shen Yi; Tang Wei Xue; Duan Hong; Tang Li 2003: Study the pharmacodynamics of the cisplatin and etoposide to human lung cancer cell line PAa and PG Fudan Xuebao (Yixuekexueban) 30(1): 56-58
Mead, G.M.; Thompson, J.; Sweetenham, J.; Whitehouse, J.M.A.; Williams, C.J. 1986: Etoposide based combination chemotherapy for extensive small cell lung cancer randomization between one or five days oral etoposide Proceedings American Society of Clinical Oncology Annual Meeting 5: 176
Wolf, M.; Havemann, K.; Holle, R.; Gropp, C.; Drings, P.; Hans, K.; Schroeder, M.; Heim, M.; Dommes, M.; Mende, S. 1987: Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 5(12): 1880-1889
Miyamoto, H.; Kawakami, Y.; Arimoto, T.; Asakawa, M.; Suzuki, A.; Fujikane, T.; Onodera, S.; Nakabayashi, T.; Yasuda, S.; Shimizu, T. 1991: Cisplatin etoposide versus cisplatin/etoposide/ifosfamide combination chemotherapy in small-cell lung cancer: a multicenter randomized controlled study. Hokkaido Study Group of Treatment for Small-Cell Lung Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 18(7): 1127-1134